Stock OXIS INTERNATIONAL
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Oxis International OTC Bulletin Board

Equities

US6918295014

Pharmaceuticals

Business Summary

GT Biopharma, Inc. specializes in the research and development of therapeutic products used primarily for the treatment of cancer and disorders of the central nervous system.

The group has a portfolio of 3 products in clinical development phase (GTB-3550, GTB-3650 and GTB-5550; treatment of leukemia and solid tumors).

Managers

Managers TitleAgeSince
Michael Breen CEO
 Chief Executive Officer 61 13/21/13
Manu Ohri DFI
 Director of Finance/CFO 68 18/22/18
Jeffrey Miller PRN
 Corporate Officer/Principal - 14/22/14

Members of the board

Members of the board TitleAgeSince
Charles Casamento BRD
 Director/Board Member 78 01/23/01
Bruce Wendel BRD
 Director/Board Member 70 11/20/11
Rajesh Shrotriya BRD
 Director/Board Member 79 13/21/13
Michael Breen CEO
 Chief Executive Officer 61 13/21/13

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 96,230 0 0 56.50 %
Stock B 1 2,156,651 1,272,830 ( 59.02 %) 0

Shareholders

NameEquities%Valuation
DekaBank Deutsche Girozentrale
79.21 %
1,093,645 79.21 % 4 M $
Bristol Capital Advisors LLC
13.76 %
190,000 13.76 % 712 880 $
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.
6.653 %
91,860 6.653 % 344 659 $
Armistice Capital LLC
5.252 %
72,511 5.252 % 272 061 $
Michael Breen
2.067 %
28,540 2.067 % 107 082 $
Vanguard Group, Inc. (Subfiler)
1.486 %
20,512 1.486 % 76 961 $
BMO Bank NA (Investment Management)
1.439 %
19,872 1.439 % 74 560 $
Bruce Wendel
0.8514 %
11,755 0.8514 % 44 105 $
Manu Ohri
0.8450 %
11,666 0.8450 % 43 771 $
Geode Capital Management LLC
0.8101 %
11,184 0.8101 % 41 962 $

Company contact information

GT Biopharma, Inc.

8000 Marina Boulevard Suite 100

94005, Brisbane

+415 919 4040

http://www.gtbiopharma.com
address Oxis International

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+38.59% 727B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.89% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.66% 328B
ABBVIE INC. Stock AbbVie Inc.
+0.24% 277B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.47% 243B
NOVARTIS AG Stock Novartis AG
+7.35% 205B
ROCHE HOLDING AG Stock Roche Holding AG
-6.42% 203B
AMGEN INC. Stock Amgen Inc.
+4.23% 164B
PFIZER, INC. Stock Pfizer, Inc.
-1.70% 164B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. GTBP Stock
  4. Stock
  5. Company Oxis International